Browsing by Author Delamain, Marcia Torresan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 12 of 12
PreviewIssue DateTitleAuthor(s)AdvisorType
2015Bcr-abl1 Transcript Levels At 3 And 6 Months Are Better For Identifying Chronic Myeloid Leukemia Patients With Poor Outcome In Response To Second-line Second-generation Tyrosine Kinase Inhibitors After Imatinib Failure: A Report From A Single Institution.Ribeiro, Beatriz Felicio; Vergílio, Bruna Rocha; Miranda, Eliana Cristina Martins; Almeida, Maria Helena; Delamain, Marcia Torresan; da Silveira, Rosana Antunes; de Souza, Carmino Antonio; Albuquerque, Dulcinéia Martins; Dos Santos, Andrey; Duarte, Vagner Oliveira; Oliveira-Duarte, Gislaine Borba; Lorand-Metze, Irene; Pagnano, Katia Borgia Barbosa-Artigo de periódico
1-Jan-2013Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcomeBenites, Bruno Deltreggia; Lima, Carolina Silva Costa; Lorand-Metze, Irene; Delamain, Marcia Torresan; Oliveira, Gislaine Borba; Almeida, Daiane de; Souza, Carmino Antonio de; Vassallo, Jose; Pagnano, Katia Borgia Barbosa-Artigo de periódico
1-Dec-2011Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomasDuarte, Bruno Kosa Lino; Miranda, Eliana Cristina Martins; Nucci, Marcio; Vigorito, Afonso Celso; Penteado, Francisco José; Marques Jr, José Francisco Comenalli; Oliveira-Duarte, Gislaine Borba; Lorand-Metze, Irene Gyongyver Heidemarie; Pagnano, Katia Borgia; Delamain, Marcia Torresan; Baldissera, Renata; Valente, Isabella Salvetti; Souza, Carmino Antonio de-Artigo de periódico
2011Monitoring Of Bcr-abl Levels In Chronic Myeloid Leukemia Patients Treated With Imatinib In The Chronic Phase - The Importance Of A Major Molecular Response.Machado, Melissa Pereira; Tomaz, Juarez Pires; Lorand-Metze, Irene; de Souza, Cármino Antonio; Vigorito, Afonso Celso; Delamain, Marcia Torresan; Bendit, Israel; Pereira, Noemi Farah; Pagnano, Katia Borgia Barbosa-Artigo de periódico
2011Brazilian Experience Using High Dose Sequential Chemotherapy Followed By Autologous Hematopoietic Stem Cell Transplantation For Malignant Lymphomas.Duarte, Bruno Kosa Lino; Miranda, Eliana Cristina Martins; Nucci, Marcio; Vigorito, Afonso Celso; Penteado, Francisco José; Marques, José Francisco Comenalli; Oliveira-Duarte, Gislaine Borba; Lorand-Metze, Irene Gyongyver Heidemarie; Pagnano, Katia Borgia; Delamain, Marcia Torresan; Baldissera, Renata; Valente, Isabella Salvetti; de Souza, Carmino Antonio-Artigo de periódico
2013Primary Myelofibrosis: Risk Stratification By Ipss Identifies Patients With Poor Clinical Outcome.Benites, Bruno Deltreggia; Lima, Carolina Silva Costa; Lorand-Metze, Irene; Delamain, Marcia Torresan; Oliveira, Gislaine Borba; Almeida, Daiane de; Souza, Carmino Antonio de; Vassallo, Jose; Pagnano, Katia Borgia Barbosa-Artigo de periódico
2019Increased risk of Hodgkin lymphoma in males with inherited T lymphocyte receptor programed death-1 deficiencyDelamain, Marcia Torresan; Boas Gomez, Gabriela Vilas; Lourenco, Gustavo Jacob; de Souza, Carmino Antonio; Passos Lima, Carmen Silvia-Outro documento
2019Cardiovascular risk and cardiovascular events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsAssunção, Paola Morelato; Lana, Tamires Prates; Delamain, Marcia Torresan; Duarte, Gislaine Oliveira; Zulli, Roberto; Lorand-Metze, Irene; de Souza, Carmino Antonio; de Paula, Erich Vinicius; Barbosa Pagnano, Katia Borgia-Artigo
2019Primary infratentorial diffuse large b-cell lymphoma: a challenging diagnosis in an immunocompetent patientBeraldo, Gabriel Laverdi; Carvalho Brito, Angelo Borsarelli; Delamain, Marcia Torresan; de Souza, Carmino Antonio; Passos Lima, Carmen Silvia; Leite Bonfitto, Joao Felipe; Queiroz, Luciano de Souza; Reis, Fabiano-Artigo
2019Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind studyCandelaria, Myrna; Gonzalez, Derlis E.; Delamain, Marcia Torresan; Bar, Daniel Oscar; Beniwal, Surender Kumar; Dasappa, Lokanatha; Flores, David Hugo; Querol, John; Guan, Toh See; Lipatov, Oleg Nikolaevich; Volodicheva, Elena Mikhailovna; Patel, Moosa; Nodehi, Sayyed Reza S-Artigo
2011Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular responseMachado, Melissa Pereira; Tomaz, Juarez Pires; Lorand-Metze, Irene; Souza, Cármino Antonio de; Vigorito, Afonso Celso; Delamain, Marcia Torresan; Bendit, Israel; Pereira, Noemi Farah; Pagnano, Katia Borgia Barbosa-Artigo
2019Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 studyLuminari, Stefano; Merli, Michele; Rattotti, Sara; Tarantino, Vittoria; Marcheselli, Luigi; Cavallo, Federica; Varettoni, Marzia; Bianchi, Benedetta; Merli, Francesco; Tedeschi, Alessandra; Cabras, Giuseppina; Re, Francesca; Visco, Carlo; Delamain, Marcia Torresan; Cencini, Emanuele; Spina, Michele; Ferrero, Simone; Ferrari, Angela; Deodato, Marina; Mannina, Donato; Annibali, Ombretta; Rago, Angela; Orsucci, Lorella; Defrancesco, Irene; Frigeni, Marco; Cesaretti, Marina; Arcaini, Luca-Artigo